Reaction Details Report a problem with these data
Target
Cathepsin S
Ligand
BDBM315331
Substrate
n/a
Meas. Tech.
Cathepsin Enzyme Inhibition Assay
IC50
585±n/a nM
Citation
 Haap, W; Kuehne, H; Mauser, H Piperidine derivatives US Patent  US10172843 Publication Date 1/8/2019 
Target
Name:
Cathepsin S
Synonyms:
CATS_HUMAN | CTSS | Cathepsin S (Cat S) | cathepsin S preproprotein
Type:
Protein
Mol. Mass.:
37507.38
Organism:
Homo sapiens (Human)
Description:
P25774
Residue:
331
Sequence:
MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI
  
Inhibitor
Name:
BDBM315331
Synonyms:
1-Methyl-3-{1-[2- methyl-5-(4- trifluoromethyl-phenyl)- 2H-[1,2,4]triazol-3- ylmethyl]-piperidin-4- yl}-1,3-dihydro- benzoimidazol-2-one | US10172843, Example 65
Type:
Small organic molecule
Emp. Form.:
C24H25F3N6O
Mol. Mass.:
470.4901
SMILES:
Cn1nc(nc1CN1CCC(CC1)n1c2ccccc2n(C)c1=O)-c1ccc(cc1)C(F)(F)F
Structure:
Search PDB for entries with ligand similarity: